Wockhardt ltd
Wockhardt is a global pharmaceutical and biotechnology wockhardt ltd engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals creams and ointments. Market Position The Co. Please exercise caution and do your own analysis. Consolidated Figures in Rs.
Being different and making a difference. That sums up the vision, philosophy, conviction and driving force behind Dr. Habil F Khorakiwala who revels in venturing down the road less travelled. He founded Wockhardt in Our investors, Wockhardt shareowners, are an important and valued constituent of the Wockhardt stakeholder universe.
Wockhardt ltd
The Estimates data displayed by Moneycontrol is not a recommendation to buy or sell any securities. The Company advises the users to check with duly registered and qualified advisors before taking any investment decision. The Company or anyone involved with the Company will not accept any liability for loss or damage as a result of reliance on the Estimates data. Note : Support and Resistance level for the day, calculated based on price range of the previous trading day. Note : Support and Resistance level for the week, calculated based on price range of the previous trading week. Note : Support and Resistance level for the month, calculated based on price range of the previous trading month. Read 1 investor views. Posted by : attota. Posted by : ThinkStocks. See More. Which stock to buy and why? Make an informed investment decision with advanced AI-based features like SWOT analysis, investment checklist, technical ratings and know how fairly the company is valued.
Key Financial Charts.
Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai , India. It produces formulations , biopharmaceuticals , nutrition products, vaccines and active pharmaceutical ingredients APIs. Wockhardt was founded by Dr. Habil Khorakiwala in the s. Khorakiwala had acquired Worli Chemical Works [8] in This was incorporated as Wockhardt Pvt. In , it expanded into biotechnology , and subsequently started producing intravenous fluids.
Being different and making a difference. That sums up the vision, philosophy, conviction and driving force behind Dr. Habil F Khorakiwala who revels in venturing down the road less travelled. He founded Wockhardt in Our investors, Wockhardt shareowners, are an important and valued constituent of the Wockhardt stakeholder universe. While it is a matter of regulatory compliance, we also consider it as good governance and our duty and responsibility, to keep our investors informed and updated regularly about news, events and developments that impact our business and operations. Wockhardt is a leading, research-based, global enterprise with relevance in the fields of pharmaceuticals, biotechnology, and healthcare services. WCK administered on compassionate ground and saved 20 lives. Now in Global phase III clinical trial.
Wockhardt ltd
Wockhardt is a true Indian multi-national company with a multi-ethnic workforce of 8, Wockhardt associates from 21 different nationalities globally. It has three research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients APIs and vaccines. For more information, please visit www. Wockhardt is a business in transition.
Kiss fm playlist
Habil Khorakiwala in the s. Piotroski Score i. Marg, Vikhroli West ,","address2":"","address3":"","address4":"","telephone":", ","fax":"","email":"rnt. The Estimates data displayed by Moneycontrol is not a recommendation to buy or sell any securities. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Note : Support and Resistance level for the week, calculated based on price range of the previous trading week. Read Edit View history. Website www. Traded as. Select Item. Quarterly Annually. Close Ad. Sun Pharma. Click here for disclaimer. In new drug discovery area, they have developed a number of lead molecules in the anti-infective field.
Habil Khorakiwala founded Wockhardt in
Ex-Right Ratio Premium. Promoter Decreasing Holding. Rakesh Jhunjhunwala and Associates 2. Premium features. Save hours of research time and resources with our up-to-date Wockhardt Ltd Strategy Report Understand Wockhardt Ltd position in the market, performance and strategic initiatives. High Our Business. Advanced charts with more than technical indicators, tools and studies will give you the edge, making it easier to negotiate the market and its swings. Search our premium data. Tools Tools. The company has delivered a poor sales growth of
You have hit the mark. Thought excellent, it agree with you.
You commit an error. Let's discuss it. Write to me in PM, we will talk.
Bravo, excellent idea and is duly